Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in second-line metastatic renal cell carcinoma
NCT00054886Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00054886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054886.